← Back to Search

Stress Management and Resiliency Training for Depression (SMART-D) Therapy for Depression

N/A
Waitlist Available
Led By Ashok Seshadri, MD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 week, 8 week, 3 month, 6 month
Awards & highlights

Study Summary

This trial is testing if a therapy that helps manage stress and build resiliency will also help treat major depression.

Eligible Conditions
  • Depression

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 week, 8 week, 3 month, 6 month
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 week, 8 week, 3 month, 6 month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in patient health questionnaire depression assessment
Change in severity of depression
Secondary outcome measures
Change in measures of resilience
Changed in perceived stress scale

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: SMART-D Intervention GroupExperimental Treatment1 Intervention
Subjects will participate in Stress Management and Resiliency Training for Depression (SMART-D) therapy as well as treatment as usual which consists of any ongoing medication or psychotherapy based treatments that are currently in place.
Group II: Standard of Care GroupActive Control1 Intervention
Treatment as usual will consist of any ongoing medication or psychotherapy based treatments that are currently in place.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Stress Management and Resiliency Training for Depression (SMART-D) Therapy
2020
N/A
~30

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,233 Previous Clinical Trials
3,771,799 Total Patients Enrolled
39 Trials studying Depression
3,528 Patients Enrolled for Depression
Ashok Seshadri, MDPrincipal Investigator - Mayo Clinic
Mayo Clinic

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment still available for this research endeavor?

"Affirmative. According to the details posted on clinicaltrials.gov, this research study is currently recruiting participants who meet its criteria. It was first initiated on December 18th 2020 and most recently updated on February 10th 2022; with a goal of enrolling 80 individuals across 3 medical centres."

Answered by AI

Is there an age limit preventing senior citizens from participating in this research?

"The age requirements to join this trial are between 25 and 80 years old, according to the parameters outlined in its eligibility criteria."

Answered by AI

What qualifications must prospective participants satisfy to join this trial?

"This trial seeks to enrol 80 melancholic individuals aged between 25 and 80. Eligibility criteria include: having a diagnosis of major depression from the Mayo Clinic Depression Center, being partially or nearly remitted with PHQ-9 scores ≤14, consenting to audio recording of random group sessions which will be disclosed at the final study session., possessing no co-morbid diagnoses like persistent depressive disorder and generalized anxiety disorders, and continuing taking medications prescribed by their clinical treatment team."

Answered by AI

How many volunteers are currently participating in this medical trial?

"Affirmative, the information available on clinicaltrials.gov confirms that enrolment is open for this investigation. Initially posted on December 18th 2020 and most recently updated February 10th 2022, it seeks 80 participants to be sourced from 3 distinct sites."

Answered by AI
~6 spots leftby May 2025